About remifentan il hcl
Ultra-short-acting opioid analgesic
Used for
- Opioid pain relief during general anesthesia
- Pain relief during monitored anesthesia care
Usual adult dose
Given by continuous IV infusion during anesthesia; commonly 0.05–2 micrograms/kg/min, adjusted by the anesthetist.
Usual dose in children
Used during anesthesia in children; doses vary by age, procedure, and anesthetic plan.
Common side effects
- Slow or stopped breathing
- Slow heart rate and low blood pressure
- Muscle stiffness
- Nausea and vomiting
Important warnings
- Must be given by trained clinicians with airway and resuscitation equipment available.
- Can cause profound respiratory depression, especially with other sedatives or opioids.
- Rapidly wears off after stopping; alternative pain relief may be needed.
- May cause dependence and misuse.
Pregnancy
Use only when clinically necessary; it can affect the newborn’s breathing if given near delivery.
Breastfeeding
Breastfeeding guidance depends on the dose and timing; consult a clinician after anesthesia.
Interactions
- Other opioids, benzodiazepines, anesthetics, and alcohol increase sedation and breathing risks.
- Blood-pressure-lowering medicines may increase low blood pressure.
- Heart-rate-lowering medicines may increase bradycardia.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.